At a glance
ClinicalIndex Comparison RecordN/ACompleted· 432 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Oncopanel Pilot (TOP) Study
In Brief
An observational study for Colorectal Cancer Metastatic and 4 related conditions. Completed, enrolled 432 participants across 5 sites.
Detailed Summary
The BCCA Oncopanel is a clinical assay being developed to determine genotype status of a prospectively defined set of genes. The purpose of this pilot study is to assess the feasibility and effect on clinical-decision-making of the Oncopanel test. Eligible patients are those with advanced lung, colorectal, melanoma and GIST cancers and patients with diagnosed malignancies being considered for clinical trials.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer Metastatic, Advanced Non-Small Cell Lung Carcinoma, Advanced Melanoma, Gastrointestinal Stromal Tumors, Patients With Diagnosed Malignancies Being Considered for Clinical Trials
CountriesCanada
CollaboratorsBC Cancer Foundation
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2014
Enrollment StartOct 2014
Primary CompletionMar 2017
TodayJul 2026
First PostedJun 24, 2014
Enrollment StartOct 1, 2014
Primary CompletionMar 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 12.0 years ago